NCT03291756
CorEvitas Multiple Sclerosis (MS) Registry
Enrolling by Invitation
Not specifiedAges 18+ObservationalCorEvitasGovernment-funded
~1,000 participants
Updated 2026-02-09 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients with adverse events (AEs) or serious adverse events (SAEs).
Measured over Time Frame: A minimum of 10 years from last patient enrolled
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Number of patients with adverse events (AEs) or serious adverse events (SAEs).Time Frame: A minimum of 10 years from last patient enrolled
Targeted events include malignancy, anaphylaxis, cardiovascular disease, serious infection, autoimmune disease, MS Relapse, hepatic events, and general serious adverse events. An AE is any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE is an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.